science-review.ru
Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452
ISSN 2500-0780
ПИ №ФС77-57452
THE PLACEBO CONTROLLEDSAFETY STUDY OF THE ALPHA RHYTHM SPECTRUM POWER ENHANCEMENT NEUROFEEDBACKPROTOCOL IN THE HIGH QUALIFICATION ATHLETES
193 KB
We have done the placebo controlled safety study of the neurofeedback protocol of the alpha rhythm spectrum power enhancement in the C3A1 monopolar leadin the athletes of high qualification. Design of the survey was prospective randomized monocentric single-blind comparative placebo-controlled study. The first endpoint of safety estimation was the early termination of participation in the study because of adverse events. The second endpoint of safety estimation was the type and frequency of adverse events. The study included134 athletes of high qualification. By the method of lottery randomization 122 participants were included in theneurofeedback group and 12 participants were included in the placebo group.Neurofeedback intervention based on Peniston protocol.We have obtained data on the safety of the modified neurofeedback protocol in the above purposes on the criterion of early termination of participation in the study due to adverse effects of the intervention. It is shown that the course of neurofeedback not accompanied by the emergence of new types of adverse events or side effects. We have noted that the placebo may be accompanied by an increase in average of electromyogram and frequency of complaints of headache.